Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Glenmark Generics Recalling Birth Control Pills

By Pharmaceutical Processing | February 27, 2012

NEW YORK (AP) — Drugmaker Glenmark Generics said Friday it is recalling seven lots of birth control pills because in some packages, the pills were in the wrong order.

The company, which is based in India, did not say how many pills or packages are being recalled. Glenmark said the pills were distributed between Sept. 21 and Dec. 30. The ingredients of the pills are norgestimate and ethinyl estradiol.

In some packages, blisters of pills were rotated so they were not in the proper sequence. The error also made the lot number and expiration date harder to see, and company said the recall applies to any blister package for which the lot number and expiration date are not visible.

A month’s supply of birth control pills contains three different medications that are each taken one a day for a week, and a week’s worth of inert pills. If the pills are taken out of order, they may not work. Glenmark’s pills were intended to be taken in this order: seven off-white tablets, seven light blue tablets and seven blue tablets, followed by a week of green placebo pills.

When taken properly, birth control pills are nearly 100 percent effective.

Pfizer Inc., the largest drugmaker in the world, announced a similar recall on Feb. 1. The company pulled about 1 million packets of Lo/Ovral-28 and its generic equivalent off the market, although it announced that only about 30 packets had the pills out of order.

 

 

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE